The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

Share Price Information for Bushveld Minerals (BMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.57
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.57
BMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

27 Dec 2023 14:30

RNS Number : 9660X
Bushveld Minerals Limited
27 December 2023

Market Abuse Regulation ("MAR") Disclosure

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

27 December 2023

Bushveld Minerals Limited

("Bushveld" or the "Company")

General Meeting Results

Bushveld Minerals Limited (AIM: BMN), the integrated primary vanadium producer, is pleased to announce that all ordinary and special resolutions put to shareholders at the General Meeting held earlier today were duly passed.

No.

Ordinary Resolution

Votes

In Favour

Against

Withheld

1

To grant the Directors the authority to issue the New Shares, the BEE Consortium Pre-emption Shares and the SPR Option Shares and the maximum number of Orion Conversion Shares that may be issuable on an Orion Conversion in accordance with Article 8.3 of the Articles ("Resolution 1" of the circular)

779,492,174

11,854,933

927,811

2

To provide the flexibility to the Directors to issue shares from time to time and grant the authority until the next annual general meeting (unless such authority is revoked or renewed prior to such time) by authorising the Directors in accordance with Article 8.3 of the Articles to issue relevant securities up to an aggregate nominal amount equal to approximately one third of the Enlarged Share Capital ("Resolution 3" of the circular).

775,167,570

16,178,973

928,375

Special Resolution

3

To grant the Directors the authority to issue the New Shares, the BEE Consortium Pre-emption Shares and the SPR Option Shares and the maximum number of Orion Conversion Shares that may be issuable on an Orion Conversion as if the pre-emption rights contained in Article 9.2 of the Articles did not apply to such issue ("Resolution 2" of the circular).

777,189,029

13,283,193

1,802,696

4

To disapply the pre-emption rights contained in Article 9.9 of the Articles in respect of the issuance of equity securities for cash pursuant to rights issues and other pre-emptive issues, and in respect of other issues of equity securities for cash up to an aggregate nominal value which equates to approximately 10 per cent of the Enlarged Share Capital ("Resolution 4" of the circular).

777,440,625

13,253,943

1,580,350

Admission, Settlement and Total Voting Rights

An application has been made to the London Stock Exchange for the 395,897,277 Fundraise Shares and 124,267,747 Orion Shares to be admitted to trading on AIM. It is expected that Admission will become effective and dealings in the Fundraise Shares and Orion Shares to be issued pursuant to the Fundraise will commence on or around 28 December 2023.

Following Admission, there will be a total of 2,311,213,138 Ordinary Shares in issue, 670,000 of which are held in treasury. Shareholders should use the figure of 2,310,543,138 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the FCA's Disclosure and Transparency Rules.

The new Ordinary Shares to be issued pursuant to the PrimaryBid Offer will be issued free of all liens, charges and encumbrances and will, on Admission, rank pari passu in all respects with the new Ordinary Shares to be issued pursuant to the Placing, the Subscription and the Company's existing Ordinary Shares.

Furthermore, as announced on 5 December 2023, Acacia Resources Limited subscribed for 92,592,592 new ordinary shares of 1 pence each in the Company, which will be settled on or before 28 February 2024. A separate AIM application and announcement will be made regarding the admission of these shares to trading on AIM.

Craig Coltman, CEO of Bushveld Minerals Limited, commented:

"I would like to thank the shareholders for voting in favour of all the resolutions. Your support is of utmost importance as the equity raise which will provide the necessary resources for the Company to meet its financial obligations, increase production and ensure stability."

Enquiries: info@Bushveldminerals.com

Bushveld Minerals Limited

+27 (0) 11 268 6555

Craig Coltman, Chief Executive Officer

Chika Edeh, Head of Investor Relations

SP Angel Corporate Finance LLP

Nominated Adviser, Joint Broker & Joint Bookrunner

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

Grant Barker / Richard Parlons

Hannam & Partners

Joint Broker & Joint Bookrunner

+44 (0) 20 7907 8500

Andrew Chubb / Matt Hasson / Jay Ashfield

Tavistock

Financial PR

+44 (0) 207 920 3150

Gareth Tredway / Tara Vivian-Neal / James Whitaker

ENDS

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a vertically integrated primary vanadium producer, it is one of only three operating primary vanadium producers. In 2022, the Company produced more than 3,800 mtV, representing approximately three per cent of the global vanadium market. With a diversified vanadium product portfolio serving the needs of the steel, energy and chemical sectors.

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ROMXDLFLXLLZFBE
Date   Source Headline
26th Jan 20227:00 amRNSQ4 and Full Year 2021 Operational Update
19th Jan 20227:00 amRNSRevised Arrangement on Mustang's VRFB-H Investment
17th Jan 20222:41 pmRNSFurther Update on VRFB-H Investment by Mustang
11th Jan 20223:27 pmRNSUpdate on VRFB Holdings Limited Investment
30th Dec 20217:00 amRNSTermination of Corporate Broker Services
16th Nov 20214:58 pmRNSHolding(s) in Company
8th Nov 20212:12 pmRNSRepayment of Duferco loan note and issue of shares
27th Oct 20217:00 amRNSRepayment of Duferco convertible loan note
21st Oct 20217:00 amRNSQ3 and 9 months 2021 Operational Update
27th Sep 20217:00 amRNSInterim Results for Six Months ended 30 June 2021
20th Aug 20214:24 pmRNSPDMR Dealing to Satisfy Tax Obligations
11th Aug 20213:59 pmRNSHolding(s) in Company
6th Aug 20212:43 pmRNSIssue of Equity PDMR Dealing & Total Voting Rights
5th Aug 20215:00 pmRNSAGM Results
29th Jul 202111:41 amRNSAnnual General Meeting Webcast - Correction
28th Jul 202111:36 amRNSAnnual General Meeting Webcast
21st Jul 20217:00 amRNSQ2 2021 and H1 2021 Operational Update
14th Jul 20217:20 amRNSAnnouncement on Litigation
13th Jul 20217:00 amRNSPosting of accounts and notice of general meeting
7th Jul 202112:05 pmRNSInvestor Presentation
30th Jun 20217:38 amRNSFinal Results for the Year Ended 31 December 2020
14th May 20214:30 pmRNSHolding(s) in Company
14th May 20214:29 pmRNSHolding(s) in Company
14th May 20217:00 amRNSQ1 2021 Operational Update
27th Apr 20217:00 amRNSUpdate on Enerox GmbH Investment
21st Apr 20214:18 pmRNSUnprotected Industrial Action Resolved
19th Apr 20218:42 amRNSUnprotected Industrial Action
1st Apr 20219:04 amRNSHolding(s) in Company
1st Apr 20217:00 amRNSFollow-on investment in Enerox GmbH
30th Mar 20214:25 pmRNSHolding(s) in Company
25th Mar 20211:27 pmRNSHolding(s) in Company
26th Feb 20211:37 pmRNSTotal Voting Rights
25th Feb 20215:56 pmRNSDirector/PDMR Shareholding
19th Feb 20215:43 pmRNSDirector/PDMR Shareholding
19th Feb 20214:41 pmRNSSecond Price Monitoring Extn
19th Feb 20214:36 pmRNSPrice Monitoring Extension
19th Feb 20212:05 pmRNSSecond Price Monitoring Extn
19th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20216:04 pmRNSDirector/PDMR Shareholding
16th Feb 20215:28 pmRNSDirector/PDMR Shareholding
12th Feb 20213:28 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSQ4 and FY2020 Operational Update - Correction
4th Feb 20217:01 amRNSQ4 and Full Year 2020 Operational Update
4th Feb 20217:00 amRNSVametco Mineral Resources and Reserves update
2nd Feb 20217:00 amRNSHolding(s) in Company
2nd Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSEquity Issue, PDMR Dealing & Total Voting Rights
11th Jan 202111:12 amRNSHolding(s) in Company
11th Jan 202110:46 amRNSDeath of Ms Dolly Mokgatle

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.